by John Moore | October 16, 2018
At the recent Allscripts Client Experience (ACE, #ACEHHS18) conference, the company gave us a day and a half deep dive into their current strategy and initiatives. As much as Allscripts positioned themselves as the innovative leader among the leading EHR vendors, the fundamental reality was far simpler. This is a
by Matt Guldin | August 16, 2018
Summary: On July 9th, Cerner and Lumeris announced a 10-year, $266M partnership to build a new EHR-agnostic technology and service solution called Maestro Advantage designed for health systems transitioning to value-based care strategies. The solution will include Cerner’s HealtheIntent platform (registries, EDW, analytics, provider engagement, longitudinal record, care management) along
by Chilmark Team | July 26, 2018
By Paul Nardone, 2018 Research Intern Key Takeaways: Healthcare stakeholders recognize a social determinant of health when they see it, but organizations differ on which measures are important. Agreement about a core set of SDoH would help implementers better utilize this data type. SDoH and patient health are correlated, but
by David Constantine | May 15, 2018
A brief recap of the World Medical Innovation Forum 2018 Top minds across a broad spectrum of healthcare disciplines converged to discuss artificial intelligence in Boston April 23-25 at the 2018 World Medical Innovation Forum (WMIF), which drew 1700 registrants and 169 speakers. Researchers, clinicians and industry leadership paraded on
by John Moore | April 13, 2018
At times it can be challenging to draft commentary on all that is happening across this industry sector. Rather than write short posts for each, I have created an amalgamation of commentary to some of the more newsworthy announcements. Roche Acquires Flatiron Wow, whoever knew that data could be such
by Hannah Ehnle | April 03, 2018
This webinar complements the release of our 2018 Population Health Management Market Trends Report. The webinar is presented by the analysts behind the report, Brian Murphy, Matt Guldin and Brian Eastwood. To learn more about the report or to purchase, please click here. Enjoy! To receive the presentation slide deck,
by David Constantine | March 29, 2018
CMS decision removes important barrier for some Medicare cancer patients to access next generation sequencing and companion targeted therapies as well as potential clinical trials. For any new therapy, diagnostic or device brought forth by our healthcare innovation community, there are three high-level barriers generally encountered on the path to
by John Moore lll | February 21, 2018
For those of you who are overwhelmed by looking through the HIMSS18 session schedule (and those of you who have been meaning to look but haven't gotten to it yet), here's Chilmark Research's short list of sessions we expect to be worthwhile, as chosen by our analyst team. It is
